Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia

Journal of Clinical Investigation

Volumn 101, Issue 5, 1998, Pages 982-992

  Lawler, Jack ^a   Sunday, Mary ^b   Thibert, Valérie ^b   Duquette, Mark ^b   George, Elizabeth L ^b   Rayburn, Helen ^b   Hynes, Richard O ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Extracellular matrix; Gene knockout; Lung; Pneumonia; Thrombospondin

Indexed keywords

COLLAGEN; ELASTIN; HEMOSIDERIN; THROMBOSPONDIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; LEUKOCYTOSIS; LORDOSIS; LUNG HEMORRHAGE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

EID: 0032030891     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1684     Document Type: Article

References (69)

1. Adams, J.C., R.P. Tucker, and J. Lawler. 1995. The thrombospondin gene family. R.G. Landis, Austin. 191 pp.
2. Bornstein, P. 1995. Diversity of function is inherent in matricellular proteins. An appraisal of TSP-1. J. Cell Biol. 130:503-506.
3. Adams, J.C., and J. Lawler. 1993. Diverse mechanisms for cell attachment to platelet thrombospondin. J. Cell Sci. 104:1061-1071.
4. Asch, A.S., I. Liu, F.M. Briccetti, J.W. Barnwell, F. Kwakye-Berko, A. Dokun, J. Goldberger, and M. Pernambuco. 1993. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an eclodomain. Science. 262:1436-1440.
5. 1, as a neuronal thrombospondin receptor mediating neurite outgrowth. Neuron. 15:333-343.
6. Gao, A.-G., F.P. Lindberg, M.B. Finn, S.D. Blystone. E.J. Brown, and W.A. Frazier. 1996. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271:21-24.
7. Lawler, J., R. Weinstein, and R.O. Hynes. 1988. Cell attachment to thrombospondin. The role of ARG-GLY-ASP, calcium and integrin receptors. J. Cell Biol. 107:2351-2361.
8. Yabkowitz, R., V.M. Dixit, N. Guo, D.D. Robert, and Y. Shimizu. 1993. Activated T-cell adhesion to thrombospondin is mediated by the α4β1 (VLA-4) and α5β1 integrins. J. Immunol. 151:149-158.
9. Harpel, P.C., R.L. Silverstein, R. Pannell, V. Gurewich, and R.L. Nachman. 1990. Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. J. Biol. Chem. 265:11289-11294.
10. Mosher, D.F., T.M. Misenheimer, and J. Stenflo. 1992. Modulation of fibrinolysis by thrombospondin. Ann. NY Acad. Sci. 667:64-69.
11. Silverstein, R.L., L.L.K. Leung, and P.C. Harpel. 1985. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. J. Clin. Invest. 75:2065-2073.
12. Schultz-Cherry, S., S. Ribeiro, L. Gentry, and J.E. Murphy-Ullrich. 1994. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J. Biol. Chem. 269:26775-26782.
13. Bagavandoss, P., and J.W. Wilks. 1990. Specific inhibition of endothelial celt proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 170: 867-872.
14. Majack, R.A., S.C. Cook, and P. Bornstein. 1986. Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Prof. Natl. Acad. Sci. USA. 83:9050-9054.
15. Majack, R.A., L.V. Goodman, and V.M. Dixit. 1988. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell Biol. 106:415-422.
16. Taraboletti, G., D. Roberts, and L.A. Ltotta. 1990. Platelet thrombospondin modulates endothelial cell adhesion, motility and growth, a potential angiogenesis regulatory factor. J. Cell Biol. 111:765-772.
17. Adams, J.C., and J. Lawler. 1994. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1. Mol. Biol. Cell. 5:423-437.
18. Murphy-Ullrich, J.E., S. Gurusiddappa, and W.A. Frazier. 1993. Heparin-binding peptides from thrombospondin 1 and 2 contain focal adhesion-labifizing activity. J. Biol. Chem. 268:26784-26789.
19. Corless, C.L., A. Mendoza, T. Collins, and J. Lawler. 1992. Colocalizaion of thrombospondin and syndecan during murine development. Dev: Dyn. 193:346-358.
20. Iruela-Arispe, M.L., D.J. Liska, E.H. Sage, and P. Bornstein. 1993. Differential expression of thrombospondin 1, 2 and 3 during murine development. Dev. Dyn. 197:40-56.
21. O'Shea, K.S., and V.M. Dixit. 1988. Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo J Cell Biol. 107:2737-2748.
22. O'Shea, K.S., J.S.T. Rheinheimer, and V.M. Dixit. 1990. Deposition and role of thrombospondin in the histogenesis of the cerebellar cortex. J. Cell Biol 110:1275-1283.
23. Tucker, R.P., C. Hagios, R. Chiquet-Ehrismann, and J. Lawler. 1997. In situ localization of TSP-1 and thrombospondin-3 transcripts in the avian embryo. Dev. Dyn. 208:326-337.
24. DiCesare, P.E., M. Morgelin, K. Mann, and M. Paulsson. 1994. Cartilage oligomeric matrix protein and TSP-1: purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur. J. Biochem. 223:927-937.
25. Wight, T.N., G.J. Raugi, S.M. Mumby, and P. Bornstein. 1985. Light microscopic immunolocation of thrombosponding in human tissues. J. histochem. Cytochem. 33:295-302.
26. Sage, H., F.M. Farin, G.E. Striker, and A.B. Fisher. 1983. Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochemistry. 22:2148-2155.
27. Lawler, J., M. Duquette, and P. Ferro. 1991. Characterization of the murine thrombospondin gene. Genomics. 11:587-600.
28. George, E.L., E.N. Georges-Laboussc, R.S. Pawl-King, H. Rayburn, and R.O. Hynes. 1993. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 119:1079-1091.
29. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of proto-oncogene int-2 in mouse embryonic stem cells: a general strategy for targeting mutations in non-selectable genes. Nature. 336:348-352.
30. Doetschman, T.C., H. Eistetter, M. Katz, W. Schmidt, and R. Kemler. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morph. 87:27-45.
31. Laird, P.W., A. Zijderveld, K. Lindcrs, M.A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucl. Acids Res. 19:4293.
32. Lawler, J., M. Duquette, C.A. Whittaker, J.C. Adams, K. McHenry, and D.W. DeSimone. 1993. Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J. Cell Biol. 120:1059-1067.
33. Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 382-389.
34. Dawson, A.B. 1926. A note on the staining of the skeleton of cleared specimens with alizarin Red S. Stain Technol. 1:123-145.
35. Vorbroker, D.K., S. A. Profitt, L.M. Nogee, and J.A. Whitsett. 1994. Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am. J. Physiol. 268:L647-L656.
36. Sunday, M.E., C.G. Willett, K. Patidar, and S.A. Graham. 1994. Modulation of oncogene and tumor suppressor gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasia. Lab. Invest. 70:875-888.
37. Sunday, M.E., C.G. Willett, S.A. Graham, V.I.C. Oreffo, R.I. Linnoila, and H. Witschi. 1995. Histochemical characterization of non-neuroendocrine tumors and neuroendocrine cell hyperplasia induced in hamster lung by 4-(methylnitro-samino)-1-(3-pyridyl)-1-butanone with or without hyperoxia. Am J Pathol. 147:740-752.
38. 4. Nature. 227:680-685.
39. Lawler, J., L.H. Derick, J.E. Connolly, J.-H. Chen, and F.C. Chao. 1985. The structure of human platelet thrombospondin. J. Biol. Chem. 260:3762-3772.
40. Dejana, E., A. Callioni, A. Quintana, and G. De Gaetano. 1979. Bleeding time in laboratory animals. II. A comparison of different assay conditions in rats. Thromb. Res. 15:191-197.
41. Tolsma, S.S., O.V. Volpert, D.J. Good, W.A. Frazier, P.J. Polverini, and N. Bouck. 1993. Peptides derived from two separate domains of the matrix protein TSP-1 have anti-angiogenic activity two seperate domains of the matrix protein TSP-1 have anti-angiogenic activity. J. Cell Biol. 122:497-511.
42. Leung, L.L.K. 1984. Role of thrombospondin in platelet aggregation. J. Clin. Invest. 74:1764-1772.
43. Dixit, V.M., D.M. Haverstick, K.M. O'Rourke, S-W. Hennessy, G.A. Grant, S.A. Santoro, and W.A. Frazier. 1985. A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc. Natl. Acad. Sci. USA 82:3472-3476.
44. Kao, K.J., D.M. Shaut, and P.A. Klein. 1986. Functional involvement of thrombospondin in platelet aggregation induced by low versus high concentrations of thrombin. Thromb. Haemostasis. 55:136-142.
45. Asch, A.S., L.L.K. Leung, M.J. Polley, and R.L. Nachman. 1995. Platelet membrane topography: colocalization of thromhospondin and fibrinogen with glycoprotein IIb-IIIa complex. Blood. 66:926-934.
46. Legrand, C.,V. Thibert, V. Dubernard, B. Begault, and J. Lawler. 1992. Molecular requirements for the interaction of thrombospondin with thrombinactivated human platelets: modulation of platelet interaction Blood. 79:1995-2003.
47. Brookfield, J. 1992. Can genes be truly redundant? Curr. Biol. 2:553-554.
48. Hynes, R.O. 1996. Targeted mutations in cell adhesion genes: What have we learned from them? Dev. Biol. 180:402-412.
49. Rudnicki, M.A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of MyoD in mice leads to upregulation of the myogenic HLH gene Mfy-5 and results in apparently normal muscle development. Cell. 71:383-390.
50. Kuhn, C., and R. Mason. 1995. Immunolocalization of SPARC, tenascin and thrombospondin in pulmonary fibrosis. Am. J. Pathol. 147:1759-1769.
51. Kulkarni, A.B., C-G. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson. 1993. Transforming growth factor beta-1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.
52. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Alien, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992 Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:693-699.
53. Boivin, G.P., B.A. O'Toole, I.E. Ormsby, R.J. Diebold, M.J. Eis, T. Doetschman, and A.B. Kier. 1995. Onset and progression of pathological lesions in transforming growth factor-β1-deficient mice. Am. J. Pathol. 146:276-288.
54. Mansfield, P.J., L.A. Boxer, and S.J. Suchard. 1990. Thrombospondin stimulates motility of human neutrophils. J. Cell Biol. 111:3077-3086.
55. Mansfield, P.J., and S.J. Suchard. 1994. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J. Immunol. 153:4219-4229.
56. Huber, A.R., S. Ellis, K.J. Johnson, V.M. Dixit, and J. Varani, 1992. Monocyte diapedesis through an in vitro vessel wall construct: inhibition with monoclonal antibodies to thrombospondin. J. Leukocyte Biol. 52:524-528.
57. Savill, J., N. Hogg, Y. Ren, and C. Haslett. 1992. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1513-1522.
58. 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. Am. J. Pathol. 149:911-921.
59. Hughes, J., Y. Liu, J.V. Damme, and J. Savill. 1997. Human glomerular mesangial cell phagocytosis of apoptotic neutrophils: mediation by a novel CD36-independent vitronectin receptor/thrombospondin recognition mechanism that is uncoupled from chemokine secretion. J. Immunol. 158:4389-4397.
60. Magdaleno, S.M., G.Y. Wang, K.J. Jackson, M.K. Ray, S. Welty, R.H. Costa, and F.J. Demayo. 1997. Interferon-gamma regulation of Clara cell gene expression, in vivo and in vitro. Am. J. Physiol. 16:L1142-L1151.
61. Jetten, A.M., J.E. Shirtley, and G. Stoner. 1986. Regulation of proliferation of respiratory tract epithelial cells by TGF-β. Exp. Cell Res. 167:539-549.
62. Watkins, S.C., G.W. Lynch, L.P. Kane, and H.S. Slayter. 1990. Thrombospondin expression in traumatized skeletal muscle: correlation of appearance with post-trauma regeneration. Cell Tissue Res. 261:73-84.
63. DiPietro, L.A., N.N. Nissen, R.L. Gamelli, A.E. Koch, J.M. Pyle, and P.J. Polverini. 1996. TSP-1 synthesis and function in wound repair. Am. J. Pathol 148:1851-1860.
64. Raugi, G.J., J.E. Olerud, and A.M. Gown. 1987. Thrombospondin in early human wound tissue. J. Invest. Dermatol. 89:551-554.
65. Raugi, G.J., J.S. Mullen, D.H. Bark, T. Okada, and M.R. Mayberg. 1990. Thrombospondin deposition in rat carotid artery injury. Am. J. Pathol. 137:179-185.
66. Reed, M.J., L. Iruela-Arispe, E.R. O'Brien, T. Truong, T. Label, P. Bornstein, and E.H. Sage. 1995. Expression of thrombospondins by endothelial cells: injury is correlated with TSP-1. Am. J. Pathol. 147:1068-1080.
67. McGregor, B., S. Colon, M. Mutin, E. Chignier, P. Zech, and J. McGregor. 1994. Thrombospondin in human glomerulopathies. Am. J. Pathol. 144: 1281-1287.
68. Thompson, E.M., J. Hughes, S. van Noorden, J. Sharpe, and J. Savill. 1996. Expression of the multifunctional extracellular matrix protein thrombospondin in crescentic glomerulonephritis. J. Pathol. 178:89-94.
69. Polverini, PJ., L.A. DiPietro, V.M. Dixit, R.O. Hynes, and J. Lawler. 1995. TSP-1 knockout mice showed delayed organization and prolonged neovascularization of skin wounds. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9: A272.